Capricor Therapeutics (CAPR) Accounts Payables (2010 - 2026)
Capricor Therapeutics (CAPR) posted quarterly Accounts Payables of $3.9 million for Q1 2026, down 25.23% year-over-year from $5.3 million in Q1 2025, and up 137.37% quarter-over-quarter from $1.7 million in Q4 2025.
Capricor Therapeutics (CAPR) Accounts Payables (2010 - 2026) Analysis & Trends
Capricor Therapeutics' Accounts Payables history runs 17 years deep, the most recent figure standing at $3.9 million for Q1 2026.
- In Q1 2026, Accounts Payables fell 25.23% year-over-year to $3.9 million; the TTM figure through Mar 2026 stood at $3.9 million (down 25.23% YoY), while the FY2025 annual figure was $1.7 million, down 49.61% from the prior year.
- Accounts Payables for Q1 2026 stood at $3.9 million, up from $1.7 million in the prior quarter.
- The five-year high for Accounts Payables was $6.8 million in Q3 2023, with the low at $1.7 million in Q4 2025.
- The 5-year median for Accounts Payables is $4.8 million (2022), against an average of $4.7 million.
- The sharpest annual moves came in 2023 and 2025: Accounts Payables soared 75.78% in 2023, then tumbled 58.36% in 2025.
- Capricor Therapeutics' Accounts Payables stood at $4.8 million in 2022, then climbed by 29.28% to $6.3 million in 2023, then slumped by 47.46% to $3.3 million in 2024, then plunged by 49.61% to $1.7 million in 2025, then soared by 137.37% to $3.9 million in 2026.
- Business Quant data shows CAPR's Accounts Payables at $3.9 million in Q1 2026, $1.7 million in Q4 2025, and $2.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Capricor Therapeutics | 383.47 Mn | 383.47 Mn | - | 3.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.93 Mn |
| Dec 31, 2025 | 1.65 Mn |
| Sep 30, 2025 | 2.72 Mn |
| Jun 30, 2025 | 4.81 Mn |
| Mar 31, 2025 | 5.25 Mn |
| Dec 31, 2024 | 3.28 Mn |
| Sep 30, 2024 | 6.53 Mn |
| Jun 30, 2024 | 6.17 Mn |
| Mar 31, 2024 | 6.25 Mn |
| Dec 31, 2023 | 6.25 Mn |
| Sep 30, 2023 | 6.77 Mn |
| Jun 30, 2023 | 5.12 Mn |
| Mar 31, 2023 | 5.41 Mn |
| Dec 31, 2022 | 4.83 Mn |
| Sep 30, 2022 | 3.85 Mn |
| Jun 30, 2022 | 3.13 Mn |
| Mar 31, 2022 | 3.52 Mn |
| Dec 31, 2021 | 3.12 Mn |
| Sep 30, 2021 | 2.99 Mn |
| Jun 30, 2021 | 3.17 Mn |